Intellia Therapeutics Inc (NTLA)

Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	115.99% -1.917	11.99	13.59	12.61	13.57
Operating Expenses	3.58% 137.97	143.10	145.93	124.56	123.66
Benefits Costs and Expenses	8.98% 130.24	143.10	145.93	115.73	126.98
Costs And Expenses	3.58% 137.97	143.10	145.93	124.56	123.66
Operating Income/Loss	6.70% -139.89	-131.11	-132.33	-111.96	-110.09
Income/Loss Before Equity Method Investments	0.14% -127.43	-127.25	-128.33	-100.08	-110.16
Income/Loss From Equity Method Investments	22.58% -4.728	-3.857	-4.00	-3.048	-3.248
Income/Loss From Continuing Operations Before Tax	0.80% -132.16	-131.11	-123.68	-103.13	-113.41
Income/Loss From Continuing Operations After Tax	8.13% -132.16	-122.22	-123.68	-103.13	-113.41
Net Income/Loss	8.13% -132.16	-122.22	-123.68	-103.13	-113.41
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.36% 0.566	88.64	88.19	87.77	1.429
Diluted Average Shares	99.36% 0.566	88.64	88.19	87.77	1.429
Basic Earnings Per Share	5.80% -1.46	-1.38	-1.40	-1.17	-1.38
Diluted Earnings Per Share	5.80% -1.46	-1.38	-1.40	-1.17	-1.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-